Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ALAMEDA, Calif., Dec. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025.
加利福尼亞州阿拉米達，2024年12月30日 /PRNewswire/ -- Penumbra公司（紐交所代碼：PEN）今天宣佈其管理團隊定於2025年1月13日（星期一）在第43屆J.P.摩根醫療會議上進行演講。
Event: 43rd Annual J.P. Morgan Healthcare Conference
Date: Monday, January 13, 2025
Time: 6:00pm ET/3:00pm PT
活動：第43屆J.P.摩根醫療會議
日期：2025年1月13日星期一
時間：東部時間下午6:00/太平洋時間下午3:00
A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at . The webcast will be available on the company's website for at least two weeks following the event.
演講的網絡直播可以通過公司網站的「投資者」標籤下的「活動與演示」部分訪問。直播將在活動結束後至少兩個星期內在公司網站上提供。
About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit and connect on Instagram, LinkedIn and X.
關於Penumbra
Penumbra公司是全球領先的血栓切除公司，專注於開發針對缺血性中風、靜脈血栓栓塞（如肺栓塞）和急性肢體缺血等挑戰性醫療狀況的創新技術。我們豐富的產品組合，包括計算機輔助真空血栓切除（CAVT），致力於以快速、安全和簡單的方法清除從頭到腳的血栓。通過開創這些創新，我們支持來自100多個國家的醫療服務提供者、醫院和診所，致力於改善患者的治療效果和生活質量。欲了解更多信息，請訪問並在Instagram、LinkedIn和X上與我們連接。
Investor Relations
Penumbra, Inc.
[email protected]
投資者關係
Penumbra, Inc.
[email protected]
SOURCE Penumbra, Inc.
信息來源：Penumbra, Inc.
